Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.
van den Hoek
Anita M
AM
Organization of Applied Scientific Research-Prevention and Health, Gaubius Laboratory, Leiden, The Netherlands.
Voshol
Peter J
PJ
Karnekamp
Barbara N
BN
Buijs
Ruud M
RM
Romijn
Johannes A
JA
Havekes
Louis M
LM
Pijl
Hanno
H
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002552:Cerebral Ventricles / Q000187:drug effects / Q000502:physiology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D015309:Glucose Clamp Technique; D005990:Glycerol / Q000097:blood; D006946:Hyperinsulinism / Q000097:blood; D007263:Infusions, Parenteral; D007328:Insulin / Q000494:pharmacology*; D007700:Kinetics; D008079:Lipoproteins, VLDL / Q000037:antagonists & inhibitors / Q000096:biosynthesis* / Q000097:blood; D051379:Mice; D009478:Neuropeptide Y / Q000008:administration & dosage / Q000494:pharmacology*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D008079:Lipoproteins, VLDL; D009478:Neuropeptide Y; D005947:Glucose; D005990:Glycerol